Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch from tenofovir to abacavir for low bone mineral density in adults with HIV-1
2010-019879-29Phase 3Completed
- Sponsor
- Fight AIDS and Infectious Diseases Foundation
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of abacavir and tenofovir disoproxil fumarate in human immunodeficiency virus infection (HIV), sponsored by Fight AIDS and Infectious Diseases Foundation. Primary endpoint: Bone mineral density at week 48. Started Apr 2010; status: completed.
02
Drugs
abacavirtenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2010-019879-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019879-29.